Encapsulation of
probiotic bacteria can enhance their functionality
when used in combination with antibiotics for treating intestinal
tract infections. The interaction strength of encapsulating shells,
however, varies among the encapsulation methods and impacts encapsulation.
Here, we compared the protection offered by encapsulating shells with
different interaction strengths toward probiotic
Bifidobacterium
breve
against simulated gastric fluid and tetracycline,
including protamine-assisted SiO
2
nanoparticle yolk–shell
packing (weak interaction across a void), alginate gelation (intermediate
interaction due to hydrogen binding), and ZIF-8 mineralization (strong
interaction due to coordinate covalent binding). The presence of encapsulating
shells was demonstrated using X-ray-photoelectron spectroscopy, particulate
microelectrophoresis, and dynamic light scattering. Strong interaction
upon ZIF-8 encapsulation caused demonstrable cell wall damage to
B. breve
and slightly reduced bacterial viability,
delaying the growth of encapsulated bacteria. Cell wall damage and
reduced viability did not occur upon encapsulation with weakly interacting
yolk–shells. Only alginate-hydrogel-based shells yielded protection
against simulated gastric acid and tetracycline. Accordingly, only
alginate-hydrogel-encapsulated
B. breve
operated synergistically with tetracycline in killing tetracycline-resistant
Escherichia coli
adhering to intestinal epithelial
layers and maintained surface coverage of transwell membranes by epithelial
cell layers and their barrier integrity. This synergy between alginate-hydrogel-encapsulated
B. breve
and an antibiotic warrants further studies
for treating antibiotic-resistant
E. coli
infections in the gastrointestinal tract.